Funding Life-Extension Research

Area of Science:

• Gerontology and Longevity Research
• Translational Medicine
• Biomedical Innovation

Background:

• Global life expectancy is rising, but often accompanied by increased years of poor health and chronic diseases in aging populations.
• These chronic conditions place a significant burden on national healthcare systems and budgets.
• Longevity research has elucidated aging mechanisms and demonstrated life extension in model organisms.

Purpose of the Study:

• To transition longevity research from laboratory findings to human applications.
• To validate the geroscience hypothesis through clinical trials.
• To explore the potential of pharmaceutical interventions to modify aging processes.

Main Methods:

• Clinical trials to test drugs targeting aging pathways.
• Investigating the efficacy of interventions in humans.
• Evaluating the geroscience hypothesis in a clinical setting.

Main Results:

• The translational phase is initiated, focusing on human clinical trials.
• Confirmation or refutation of the geroscience hypothesis is pending trial outcomes.
• Laboratory successes in extending lifespan in organisms are being translated.

Conclusions:

• The geroscience hypothesis posits that targeting aging processes can improve healthspan.
• Innovative funding models are necessary to support high-risk, high-reward longevity research.
• Successful translation could lead to widespread benefits for human healthspan and reduced healthcare costs.